BrainsWay to Report Fourth Quarter and Full Year 2021 Financial Results on March 9, 2022
BURLINGTON, Mass. and JERUSALEM, Feb. 28, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a...
top of page
![aspot-event[1].png](https://static.wixstatic.com/media/a8e651_08c1cd723d6e4635b76fc432b9a555b7~mv2.png/v1/fill/w_980,h_276,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/a8e651_08c1cd723d6e4635b76fc432b9a555b7~mv2.png)
News & Events
Feb 23, 2022
BrainsWay Announces Publication of Results Demonstrating Efficacy of Deep TMS™ in Treating Anxiety S
BrainsWay Announces Publication of Results Demonstrating Efficacy of Deep TMS™ in Treating Anxiety Symptoms Comorbid to Depression...
Feb 1, 2022
BrainsWay to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
BURLINGTON, Mass. and JERUSALEM, February 1, 2022 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),...
Jan 31, 2022
BrainsWay Announces Final Local Coverage Determination Issued by Regional Medicare Administrative Co
BrainsWay Announces Final Local Coverage Determination Issued by Regional Medicare Administrative Contractor Palmetto GBA Providing...
Jan 26, 2022
BrainsWay Announces Addition of Markus Heilig, M.D., Ph.D., to Scientific Advisory Board
World-Renowned Specialist in Addiction and Anxiety Treatment Joins Premier Group of Researchers and Clinicians Advising Company...
Jan 12, 2022
BrainsWay Announces Multiple Publications of New Real-World OCD Data for its Deep TMS™ System
Positive Data Support the Durability and Cost-Effectiveness of Deep TMS as a Treatment for Obsessive-Compulsive Disorder BURLINGTON, MA...
Dec 9, 2021
BrainsWay Announces Publication of Deep TMS™ Trial Results for Reduction of Heavy Drinking in Alcoho
BrainsWay Announces Publication of Deep TMS™ Trial Results for Reduction of Heavy Drinking in Alcohol-Dependent Subjects Randomized,...
Nov 17, 2021
BrainsWay Reports Third Quarter 2021 Financial Results and Operational Highlights
Revenue Growth of 34% Year-over-Year in Q3 2021 Received Regulatory Clearance for Deep TMS™ System for Treatment of Anxious Depression...
Nov 3, 2021
BrainsWay to Report Third Quarter 2021 Financial Results on November 17, 2021
BURLINGTON, Mass. and JERUSALEM, Nov. 03, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a...
Oct 12, 2021
BrainsWay Announces Prominent Addition to Scientific Advisory Board
Zafiris Daskalakis, MD, PhD to Bring Extensive Research and Clinical Expertise to Assist in Guiding Growth and Clinical Impact Strategy...
Sep 30, 2021
BrainsWay Announces Data Published in World Psychiatry on Deep Transcranial Magnetic Stimulation (De
BrainsWay Announces Data Published in World Psychiatry on Deep Transcranial Magnetic Stimulation (Deep TMS™) for Smoking Addiction...
Sep 9, 2021
BrainsWay to Participate in Two Upcoming Investor Conferences in 2021
BURLINGTON, Mass. and JERUSALEM, Sept. 09, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a...
Aug 30, 2021
BrainsWay to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
BURLINGTON, Mass. and JERUSALEM, August 30, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),...
Aug 18, 2021
FDA Clears BrainsWay Deep TMS™ System for Decreasing Anxiety Symptoms in Depressed Patients
Expanded Depression Indication Further Demonstrates Company’s Leadership Position BURLINGTON, Mass. and JERUSALEM, Aug. 18, 2021 (GLOBE...
Aug 17, 2021
BrainsWay Hosting Key Opinion Leader Webinar on its Deep TMS™ Therapy for Treating Mental Health Dis
BrainsWay Hosting Key Opinion Leader Webinar on its Deep TMS™ Therapy for Treating Mental Health Disorders BURLINGTON, MA. and JERUSALEM,...
Aug 11, 2021
BrainsWay Reports Second Quarter 2021 Financial Results and Operational Highlights
Strong Revenue Growth of 45% Year-over-Year in Q2 2021 Gained Meaningful Traction in Reimbursement for Deep TMS™ in both OCD and...
Jul 28, 2021
BrainsWay to Report Second Quarter 2021 Financial Results on August 11, 2021
CRESSKILL, N.J. and JERUSALEM, July 28, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a...
Jul 6, 2021
BrainsWay to Present at the Ladenburg Thalmann 2021 Healthcare Conference
CRESSKILL, N.J. and JERUSALEM, Israel, July 6, 2021 – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global...
bottom of page